{"id":5884,"date":"2023-03-08T15:50:11","date_gmt":"2023-03-08T15:50:11","guid":{"rendered":"https:\/\/northerncanceralliance.nhs.uk\/?page_id=5884"},"modified":"2023-09-28T13:28:07","modified_gmt":"2023-09-28T12:28:07","slug":"prostate-case-finding","status":"publish","type":"page","link":"https:\/\/northerncanceralliance.nhs.uk\/pathway\/early-diagnosis\/supporting-primary-care\/gp-contracts-primary-care-networks\/introducing-the-early-cancer-diagnosis-direct-enhanced-services-des\/prostate-case-finding\/","title":{"rendered":"Prostate Case finding"},"content":{"rendered":"<p class=\"lead\">Suggested PCN\/ practice activities to promote prostate cancer awareness and case finding in areas with poor recovery of referrals and first treatments.<\/p>\n<p><a class=\"btn btn-primary\" href=\"https:\/\/northerncanceralliance.nhs.uk\/wp-content\/uploads\/2023\/04\/Prostate-case-finding-202223-V6.pdf\">Download as PDF: Prostate case finding 202223 V6<\/a><\/p>\n<h3>General principles recommended by the Northern Cancer Alliance are:<\/h3>\n<ul>\n<li><span style=\"color: #000000;\">PSA testing can be arranged regardless of symptoms \u2013 <strong>as most early prostate cancers <span style=\"text-decoration: underline;\">do not<\/span> have symptoms<\/strong>.<\/span><\/li>\n<li><span style=\"color: #000000;\">PSA case finding work should target patients over 50 (or over 45 if risk factors) to promote the opportunity for a PSA test and leaflet.<\/span><\/li>\n<li><span style=\"color: #000000;\">Any patient requesting PSA, should be given the opportunity to have a PSA blood test, after reading the PSA shared decision making (SDM) leaflet.<\/span><\/li>\n<li><span style=\"color: #000000;\">PSA testing can be directly arranged for patient without clinical involvement or approval if they have been given access to the prostate SDM leaflet.<\/span><\/li>\n<li><span style=\"color: #000000;\">Normal PSA results do not require any further clinical input.<\/span><\/li>\n<li><span style=\"color: #000000;\">Raised PSA results will require Clinical review to determine onward referral, in line\u00a0with NICE guidelines.<\/span><\/li>\n<li><span style=\"color: #000000;\">We suggest patients &gt;80 years old, with PSA over 20, could have Fast Track Suspected Cancer referral within NG12 guidance, but GPs may wish to use clinical judgement and SDM.<\/span><\/li>\n<li><span style=\"color: #000000;\">We have no guidance as to repeat PSA testing timeframes as this isn\u2019t a screening\u00a0programme. Therefore, clinical judgement is required and expect annually testing as\u00a0minimal timing.<\/span><\/li>\n<li><span style=\"color: #000000;\">Patients with prostatism symptoms would require a clinical review to evaluation and consider investigations and potential treatments.<\/span><\/li>\n<\/ul>\n<h3>PSA Patient Prostate SDM Tool<\/h3>\n<p><a class=\"btn btn-outline-primary\" href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1061564\/PCRMP_patient_info_sheet_draft_March_2022_new.pdf\" target=\"_blank\" rel=\"noopener\">Link to PSA testing and prostate cancer SDM (NHS)<\/a><\/p>\n<h3>Prostate Cancer UK resources:<\/h3>\n<p><a class=\"btn btn-outline-primary\" href=\"https:\/\/prostatecanceruk.org\/for-health-professionals\/resources\/pcn-des\" target=\"_blank\" rel=\"noopener\">Delivering the PCN Directed Enhanced Service for Prostate Cancer<\/a><\/p>\n<p><a class=\"btn btn-outline-primary\" href=\"https:\/\/prostatecanceruk.org\/risk-checker\" target=\"_blank\" rel=\"noopener\">Prostate Risk Checker<\/a><\/p>\n<p>Dr Shaun Lackey, Clinical Lead, NCA<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Suggested PCN\/ practice activities to promote prostate cancer awareness and case finding in areas with poor recovery of referrals and first treatments. Download as PDF: Prostate case finding 202223 V6 General principles recommended by the Northern Cancer Alliance are: PSA testing can be arranged regardless of symptoms \u2013 as most early prostate cancers do not [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":3690,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/pages\/5884"}],"collection":[{"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/comments?post=5884"}],"version-history":[{"count":14,"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/pages\/5884\/revisions"}],"predecessor-version":[{"id":6387,"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/pages\/5884\/revisions\/6387"}],"up":[{"embeddable":true,"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/pages\/3690"}],"wp:attachment":[{"href":"https:\/\/northerncanceralliance.nhs.uk\/wp-json\/wp\/v2\/media?parent=5884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}